For sales

📢Highlights from the Week of 11th -18th August, 2025   in the world of pharma and healthcare! 🗞️👀

VYUHPHARMA Highlights from the Week of August 11-18, 2025 insmed The landmark FDA approval of BRINSUPRI (brensocatib) becomes first-ever treatment for non-cystic fibrosis bronchiectasis valneva Valneva's chikungunya vaccine receives an updated FDA label; the clinical hold has been lifted for the older adult population Superluminal & Lilly Superluminal Medicines and Eli Lilly partnered to develop small molecule drugs for cardiometabolic diseases and obesity (FDA Approval) (FDA, Clinical hold) Pg 1/3 (Partnership) All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.